EP 1322662 A1 20030702 - 19-NOR-17 ALPHA-PREGNA-1,3,5 (10)-TRIEN-17 BETA-OLS OF A 21,16 ALPHA-LACTONE RING
Title (en)
19-NOR-17 ALPHA-PREGNA-1,3,5 (10)-TRIEN-17 BETA-OLS OF A 21,16 ALPHA-LACTONE RING
Title (de)
19-NOR-17 ALPHA-PREGNA-1,3,5 (10)-TRIEN-17 BETA-OLE EINEM 21,16 ALPHA-LAKTONRING
Title (fr)
19-NOR-17 ALPHA-PREGNA-1,3,5(10)-TRIEN-17 BETA-OLS DOTES D'UN NOYAU DE 21,16 ALPHA-LACTONE
Publication
Application
Priority
- DE 10048634 A 20000927
- EP 0111061 W 20010925
Abstract (en)
[origin: WO0226763A1] The invention relates to novel 19-nor-17 alpha -pregna-1,3,5(10)-trien-17 beta -ols with a 21,16 alpha -lactone ring of formula (II), a method for the production thereof and pharmaceutical preparations containing said compounds in addition to 17 alpha -cyanomethylated estra-1,3,5(10)-trienes, representing intermediate products in the production of 19-nor-17 alpha -pregna-1,3,5(10)-trien-17 beta -ols. The 19-nor-17 alpha -pregna-1,3,5(10)-trien-17 beta -ols represent novel selective estrogens which, unlike classical estrogens such as estradiol, exhibit preference in favor of the estrogen alpha receptor, one of the two known estrogen receptors,.
IPC 1-7
IPC 8 full level
A61P 5/30 (2006.01); C07J 41/00 (2006.01); C07J 71/00 (2006.01)
CPC (source: EP)
A61P 5/30 (2018.01); C07J 41/0094 (2013.01); C07J 71/0005 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0226763 A1 20020404; AU 9384301 A 20020408; DE 10048634 A1 20020418; EP 1322662 A1 20030702; HU P0300504 A2 20030628; HU P0300504 A3 20031229; IL 151782 A0 20030410; NO 20025201 D0 20021030; NO 20025201 L 20021030
DOCDB simple family (application)
EP 0111061 W 20010925; AU 9384301 A 20010925; DE 10048634 A 20000927; EP 01974292 A 20010925; HU P0300504 A 20010925; IL 15178201 A 20010925; NO 20025201 A 20021030